Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice. 1993

I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
N.F. Gamaleya Institute of Epidemiology and Microbiology RAMS, Moscow, Russian Federation.

The ability of different recombinant vaccinia viruses (RVV) expressing hepatitis B virus surface antigen (HBsAg) to induce anti-HBs and anti-vaccinia virus responses has been analyzed in mice. The RVVs tested differed with regard to the original vaccinia virus strain used as vector and the site of insertion of a foreign gene. It was found that the immunological responses to RVVs based on the WR strain were higher than those to RVVs based on the Lister strain. The immunological response was also quantitatively affected by the viral TK phenotype. The presence of the preS2 region in HBsAg gene, inserted into the RVV genome, led to the induction of anti-preS2 antibodies but decreased the antibody response to the S-portion of HBsAg.

UI MeSH Term Description Entries
D008251 Macaca A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes. Ape, Barbary,Ape, Black,Ape, Celebes,Barbary Ape,Black Ape,Celebes Ape,Macaque,Apes, Barbary,Apes, Black,Apes, Celebes,Barbary Apes,Black Apes,Celebes Apes,Macacas,Macaques
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic

Related Publications

I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
February 1989, Vaccine,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
February 1990, Science in China. Series B, Chemistry, life sciences & earth sciences,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
May 2012, Cancer biotherapy & radiopharmaceuticals,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
June 1999, Journal of virology,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
June 1991, The Journal of general virology,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
January 1990, Archives of virology,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
May 1998, The Journal of veterinary medical science,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
December 1987, Biochimica et biophysica acta,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
January 1989, Chinese journal of biotechnology,
I M Grigorieva, and V G Grigoriev, and L G Zakharova, and G V Pashvykina, and V Y Shevlyagin, and A D Altstein
January 1986, Doklady Akademii nauk SSSR,
Copied contents to your clipboard!